162 related articles for article (PubMed ID: 22634837)
1. Synthesis and antiangiogenic activity of novel gambogic acid derivatives.
Chen T; Zhang RH; He SC; Xu QY; Ma L; Wang GC; Qiu N; Peng F; Chen JY; Qiu JX; Peng AH; Chen LJ
Molecules; 2012 May; 17(6):6249-68. PubMed ID: 22634837
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antiangiogenic activity of caged polyprenylated xanthones isolated from Garcinia hanburyi Hook. f.
Yang J; He S; Li S; Zhang R; Peng A; Chen L
Molecules; 2013 Dec; 18(12):15305-13. PubMed ID: 24335612
[TBL] [Abstract][Full Text] [Related]
3. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic and anticancer effects of baicalein derivatives based on transgenic zebrafish model.
Jiang X; Zhou J; Lin Q; Gong G; Sun H; Liu W; Guo Q; Feng F; Qu W
Bioorg Med Chem; 2018 Aug; 26(15):4481-4492. PubMed ID: 30098912
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of Garcinia xanthones analogues: Potent Hsp90 inhibitors with cytotoxicity and antiangiogenesis activity.
Xu X; Wu Y; Hu M; Li X; Gu C; You Q; Zhang X
Bioorg Med Chem; 2016 Oct; 24(19):4626-4635. PubMed ID: 27527413
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
[TBL] [Abstract][Full Text] [Related]
7. 5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway.
Zhu W; Fu A; Hu J; Wang T; Luo Y; Peng M; Ma Y; Wei Y; Chen L
Exp Mol Med; 2011 Mar; 43(3):146-52. PubMed ID: 21297378
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities.
Yu G; Li Z; Tang L; Xiong Q
Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis.
Chang DJ; An H; Kim KS; Kim HH; Jung J; Lee JM; Kim NJ; Han YT; Yun H; Lee S; Lee G; Lee S; Lee JS; Cha JH; Park JH; Park JW; Lee SC; Kim SG; Kim JH; Lee HY; Kim KW; Suh YG
J Med Chem; 2012 Dec; 55(24):10863-84. PubMed ID: 23186287
[TBL] [Abstract][Full Text] [Related]
10. Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.
Zhang Y; Zhang H; Chen J; Zhao H; Zeng X; Zhang H; Qing C
Invest New Drugs; 2012 Feb; 30(1):8-16. PubMed ID: 20711631
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biological Evaluation of Indole-2-carbohydrazide Derivatives as Anticancer Agents with Anti-angiogenic and Antiproliferative Activities.
Zhang J; Liu T; Chen M; Liu F; Liu X; Zhang J; Lin J; Jin Y
ChemMedChem; 2018 Jun; 13(12):1181-1192. PubMed ID: 29637713
[TBL] [Abstract][Full Text] [Related]
12. Studies on chemical-structure modification and structure-activity relationship of gambogic acid derivatives at carbon(34).
Zhang XJ; Li X; Yang YR; Sun HP; Gao Y; Zhang L; Wang JX; Guo QL; You QD
Chem Biodivers; 2012 Oct; 9(10):2295-308. PubMed ID: 23081928
[TBL] [Abstract][Full Text] [Related]
13. Studies on chemical modification and biology of a natural product, gambogic acid (II): Synthesis and bioevaluation of gambogellic acid and its derivatives from gambogic acid as antitumor agents.
Wang J; Ma J; You Q; Zhao L; Wang F; Li C; Guo Q
Eur J Med Chem; 2010 Sep; 45(9):4343-53. PubMed ID: 20605273
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and anti-proliferative evaluation of [1,1'-biphenyl]-4-ols as inhibitor of HUVEC migration and tube formation.
Ran Y; Ma L; Wang X; Chen J; Wang G; Peng A; Chen L
Molecules; 2012 Jul; 17(7):8091-104. PubMed ID: 22766801
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
16. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
[TBL] [Abstract][Full Text] [Related]
17. Novel Natural Product-like Caged Xanthones Bearing a Carbamate Moiety Exhibit Antitumor Potency and Anti-Angiogenesis Activity In vivo.
Xu X; Wu Y; Hu M; Li X; Bao Q; Bian J; You Q; Zhang X
Sci Rep; 2016 Oct; 6():35771. PubMed ID: 27767192
[TBL] [Abstract][Full Text] [Related]
18. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
19. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities.
Li YB; Wang ZQ; Yan X; Chen MW; Bao JL; Wu GS; Ge ZM; Zhou DM; Wang YT; Li RT
Cancer Lett; 2013 Oct; 340(1):88-96. PubMed ID: 23856030
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of quercetin on angiogenesis in larval zebrafish and human umbilical vein endothelial cells.
Zhao D; Qin C; Fan X; Li Y; Gu B
Eur J Pharmacol; 2014 Jan; 723():360-7. PubMed ID: 24239714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
